De Rucci Healthy Sleep Co (001323) Fair Value & Analysis
Consumer Cyclical · CN · Market cap 8.0B CNY
Fair value as of: Jul 21, 2026
From 22 valuation models · updated 20 days ago
Share price +3.0% over the past month.
A solid business, but screening 12% overvalued on our models.
What matters now
- Solid but not exceptional quality (57/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (¥11.06 to ¥26.13) leaves room in how you read the outcome.
Price vs Fair Value (4 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
49‑month range ¥15.39 – ¥41.37 · fair‑value band ¥11.06 – ¥26.13 · the ¥16.90 price screens above the ¥14.83 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 21, 2026.
Analysis
De Rucci Healthy Sleep Co (001323) currently trades at ¥16.90, while our model-based Fair Value estimate is ¥14.83, implying the stock looks roughly 12.3% overvalued today. The Quality Score stands at 57/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, De Rucci Healthy Sleep Co generated revenue of 5.3B CNY at a net margin of 9.6%. Revenue grew 5.9% year over year. It earns a return on equity of 10.8%. The balance sheet holds a net cash position of 301M CNY. Fundamentals as of Jul 21, 2026
Our scenario range runs from ¥11.06 (bear case) to ¥26.13 (bull case); at ¥16.90, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 42% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at 16% fair-value upside, at -12%, 001323 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 22 models by family
Widest divergence: Multiples (¥20.92) versus Asset-Based (¥6.84). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 57 · Market factors (momentum, volatility) 27
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
De Rucci Healthy Sleep Co., Ltd., together with its subsidiaries, engages in the research, design, development, production, and sale of healthy sleep systems in China and internationally.
Full company description
De Rucci Healthy Sleep Co., Ltd., together with its subsidiaries, engages in the research, design, development, production, and sale of healthy sleep systems in China and internationally. The company offers mattresses, bed frames, sofas, beddings, and its supporting home furnishings under the DeRUCCI, CALIAITALIA, CALIA, V6 Home Furnishings, and SleepDesigns brands. It also engages in the provision of delivery, installation, repair, and maintenance; consulting; research and development; and investing services. The company sells its products through its online store. De Rucci Healthy Sleep Co., Ltd. was founded in 2004 and is headquartered in Dongguan, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
De Rucci Healthy Sleep Co reported revenue of ¥5.2B in FY2025 versus ¥6.5B in FY2021, a compound −5.2%/yr. Reported net income was ¥536M in FY2025, compounding −6.0%/yr from FY2021.
001323 screens 12% overvalued. Compare with Midea Group →
Peer Group
Furnishings, Fixtures & Appliances · 311 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Furnishings, Fixtures & Appliances median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 40/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Furnishings, Fixtures & Appliances stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Midea Group 000333 | ¥82.71 | ¥107.22 | +30% |
| Gree Electric Appliances, Inc 000651 | ¥38.25 | ¥88.02 | +130% |
| Haier Smart Home Co 600690 | ¥21.46 | ¥36.04 | +68% |
| King Slide Works Co 2059 | 8,655 TWD | 1,917 TWD | -78% |
| Guangdong Songfa Ceramics Co 603268 | ¥155.59 | ¥38.95 | -75% |
| SharkNinja, Inc SN | $154.53 | $89.07 | -42% |
| Hisense Home Appliances Group 000921 | ¥26.33 | ¥48.03 | +82% |
| Zhejiang Supor Co 002032 | ¥43.85 | ¥44.84 | +2% |
| COWAY Co 021240 | 96,700 KRW | 112,530 KRW | +16% |
| Ecovacs Robotics Co 603486 | ¥50.13 | ¥54.11 | +8% |
Compare De Rucci Healthy Sleep Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is De Rucci Healthy Sleep Co (001323) overvalued or undervalued?
What is the fair value of 001323?
What is the quality score of 001323?
What is the revenue of De Rucci Healthy Sleep Co (001323)?
What is the net profit margin of 001323?
Does De Rucci Healthy Sleep Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track De Rucci Healthy Sleep Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.